Cargando…
Morphometric imaging biomarker identifies Alzheimer’s disease even among mixed dementia patients
A definitive diagnosis of Alzheimer’s disease (AD), even in the presence of co-morbid neuropathology (occurring in > 50% of AD cases), is a significant unmet medical need that has obstructed the discovery of effective AD therapeutics. An AD-biomarker, the Morphometric Imaging (MI) assay on cultur...
Autores principales: | Chirila, Florin V., Xu, Guang, Fontaine, Dan, Kern, Grant, Khan, Tapan K., Brandt, Jason, Konishi, Yoshihiro, Nebe-von-Caron, Gerhard, White, Charles L., Alkon, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626495/ https://www.ncbi.nlm.nih.gov/pubmed/36319674 http://dx.doi.org/10.1038/s41598-022-21796-y |
Ejemplares similares
-
Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer’s Disease Phase IIa and Expanded Access Trials
por: Nelson, Thomas J., et al.
Publicado: (2017) -
Serum NfL in Alzheimer Dementia: Results of the Prospective Dementia Registry Austria
por: Kern, Daniela, et al.
Publicado: (2022) -
Automatic Actin Filament Quantification of Osteoblasts and Their Morphometric Analysis on Microtextured Silicon-Titanium Arrays
por: Matschegewski, Claudia, et al.
Publicado: (2012) -
Survival in memory clinic cohort is short, even in young-onset dementia
por: Rhodius-Meester, Hanneke Frederica Maria, et al.
Publicado: (2019) -
The Changes in Rats with Sciatic Nerve Crush Injury Supplemented with Evening Primrose Oil: Behavioural, Morphologic, and Morphometric Analysis
por: Ramli, Danial, et al.
Publicado: (2017)